MATTHEW THOMAS MCLEAY, M.D.
Osteopathic Medicine at Cass St, Omaha, NE
License number
Nebraska 19414
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
8552 Cass St SUITE 301, Omaha, NE 68114
Phone
(402) 390-0606
(402) 390-0899 (Fax)
(402) 390-0899 (Fax)
Personal information
See more information about MATTHEW THOMAS MCLEAY at radaris.comName
Address
Phone
216 245Th Cir, Waterloo, NE 68069
7831 Chicago Ct, Omaha, NE 68114
8901 Dodge St, Omaha, NE 68114
8901 Dodge Rd, Omaha, NE 68114
12920 Eagle Run Dr, Omaha, NE 68164
Professional information
Dr. Matthew T Mcleay - MD (Doctor of Medicine)
Hospitals:
Midwest Pulmonary/Critical Care, P.C.
8552 Cass St SUITE 301, Omaha 68114
Memorial Community Hospital OP Clinic
810 N 22Nd St, Blair 68008
Midwest Sleep Center
8552 Cass St SUITE 201, Omaha 68114
Alegent Creighton Health Bergan Mercy Medical Center
7500 Mercy Rd, Omaha 68124
Alegent Creighton Health Lakeside Hospital
16901 Lakeside Hills Ct, Omaha 68130
The Nebraska Methodist Hospital
8303 Dodge St, Omaha 68114
Midwest Pulmonary/Critical Care, P.C.
8552 Cass St SUITE 301, Omaha 68114
Memorial Community Hospital OP Clinic
810 N 22Nd St, Blair 68008
Midwest Sleep Center
8552 Cass St SUITE 201, Omaha 68114
Alegent Creighton Health Bergan Mercy Medical Center
7500 Mercy Rd, Omaha 68124
Alegent Creighton Health Lakeside Hospital
16901 Lakeside Hills Ct, Omaha 68130
The Nebraska Methodist Hospital
8303 Dodge St, Omaha 68114
8552 Cass St SUITE 301, Omaha 68114
Memorial Community Hospital OP Clinic
810 N 22Nd St, Blair 68008
Midwest Sleep Center
8552 Cass St SUITE 201, Omaha 68114
Alegent Creighton Health Bergan Mercy Medical Center
7500 Mercy Rd, Omaha 68124
Alegent Creighton Health Lakeside Hospital
16901 Lakeside Hills Ct, Omaha 68130
The Nebraska Methodist Hospital
8303 Dodge St, Omaha 68114
Midwest Pulmonary/Critical Care, P.C.
8552 Cass St SUITE 301, Omaha 68114
Memorial Community Hospital OP Clinic
810 N 22Nd St, Blair 68008
Midwest Sleep Center
8552 Cass St SUITE 201, Omaha 68114
Alegent Creighton Health Bergan Mercy Medical Center
7500 Mercy Rd, Omaha 68124
Alegent Creighton Health Lakeside Hospital
16901 Lakeside Hills Ct, Omaha 68130
The Nebraska Methodist Hospital
8303 Dodge St, Omaha 68114
Education:
Medical Schools
Univ Of Ne Coll Of Med
Graduated: 1988
Univ Of Ne Coll Of Med
Graduated: 1988
Matthew Thomas McLeay, Omaha NE
Specialties:
Pulmonologist
Address:
8552 Cass St, Omaha, NE 68114
Education:
University of Nebraska, College of Medicine - Doctor of Medicine
Parkland Memorial Hospital - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
Parkland Memorial Hospital - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine), American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Matthew Thomas McLeay, Omaha NE
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease, Critical Care Medicine
Work:
Midwest Pulmonary / Critical Care
8552 Cass St, Omaha, NE 68114 Midwest Pulmonary Crtcl Care
8552 Cass St, Omaha, NE 68114 Midwest Pulmonary Crtcl Care
7831 Chicago Ct, Omaha, NE 68114 Midwest Pulmonary/Critical Care, P.C.
810 N 22Nd St, Blair, NE 68008 Mp/Cc PC
6901 N 72Nd St, Omaha, NE 68122
8552 Cass St, Omaha, NE 68114 Midwest Pulmonary Crtcl Care
8552 Cass St, Omaha, NE 68114 Midwest Pulmonary Crtcl Care
7831 Chicago Ct, Omaha, NE 68114 Midwest Pulmonary/Critical Care, P.C.
810 N 22Nd St, Blair, NE 68008 Mp/Cc PC
6901 N 72Nd St, Omaha, NE 68122
Education:
University of Nebraska (1988)
Megaribavirin Alone Or Combination Of Other Antiviral, Antioxidant And A Perflubron Emulsion For Treatment Of Viral Disease
US Patent:
2010029, Nov 25, 2010
Filed:
May 21, 2009
Appl. No.:
12/454663
Inventors:
Matthew T. McLeay - Omaha NE, US
International Classification:
A61K 9/12, A61K 31/708, A61K 38/44
US Classification:
424 45, 514 43, 424 944
Abstract:
The present invention is a novel method using a MegaRibavirin aerosol or a MegaRibavirin combination of therapeutics for the treatment of viral disease particularly the pandemic influenza strains “swine” 2009 H1N1 and H5N1. This invention utilizes Ribavirin in an aerosol Mega Dose (61-161 mg/ml) alone or combined with or without other antivirals, a perfluorocarbon emulsion and anti-inflammatory/anti-oxidants. Where applicable, the perfluorocarbon emulsion may dissolve these agents enabling a depot effect and possible protracted delivery. In addition perfluorocarbon emulsions have the possible added benefit of oxygen carrying capacity and alveolar nitric oxide sequestration, which may reduce peroxynitrite formation and decrease Influenza severity.
Anti-Fibroblastic Fluorochemical Emulsion Therapies
US Patent:
2012007, Mar 29, 2012
Filed:
Jul 1, 2011
Appl. No.:
13/175305
Inventors:
Matthew T. McLeay - Omaha NE, US
Assignee:
MTM Research LLC - Omaha NE
International Classification:
A61K 31/02, C12N 5/071, A61P 35/00, A61K 31/7068, A61K 39/395
US Classification:
4241331, 514759, 514 49, 435375
Abstract:
The present invention is directed to compositions and methods targeting tissue resident cells, such as fibroblasts, in a subject harboring conditions or at risk for conditions that would benefit from anti-fibroblastic therapy. The present invention relates to the use of fluorochemical compositions and methods of delivery that result in retention of the fluorochemical composition and any bioactive agent delivered in combination with the fluorochemical composition.